clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT02066961 |
P17 | country | Spain | Q29 |
Canada | Q16 | ||
Italy | Q38 | ||
Netherlands | Q55 | ||
Mexico | Q96 | ||
Egypt | Q79 | ||
Brazil | Q155 | ||
Germany | Q183 | ||
Singapore | Q334 | ||
France | Q142 | ||
Indonesia | Q252 | ||
Argentina | Q414 | ||
Algeria | Q262 | ||
Australia | Q408 | ||
New Zealand | Q664 | ||
Peru | Q419 | ||
Israel | Q801 | ||
United Kingdom | Q145 | ||
Austria | Q40 | ||
Colombia | Q739 | ||
Lebanon | Q822 | ||
Oman | Q842 | ||
Saudi Arabia | Q851 | ||
Taiwan | Q865 | ||
Thailand | Q869 | ||
Philippines | Q928 | ||
P582 | end time | 2019-11-01 | |
P921 | main subject | metastatic prostate carcinoma | Q55779807 |
P1132 | number of participants | 1533 | |
P1813 | short name | ASPIRE-PCa | |
P580 | start time | 2013-12-31 | |
P8363 | study type | observational study | Q818574 |
P1476 | title | A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis |